IP Library Assignment 012789/0333
Patent Assignment
Reel/Frame 012789/0333

Assignment of Assignor's Interest

Recorded: 2002-04-09 Pages: 3
Assignors
JACKOWSKI, GEORGE
Executed: 2002-03-03
MARSHALL, JOHN
Executed: 2002-03-03
Assignee
SYN X PHARMA
6354 VISCOUNT ROAD, MISSISSAUGA, ONTARIO L4V 1H3, CANADA
Covered Property (1)
Apolipoprotein Biopolymer Markers Indicative of Insulin Resistance
Patent: 7,314,762 →
Application: 09/993,366 →
Publication: US 2007/0190666
Related Assignments (7)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement Jul 18, 2003
From: SYNX PHARMA INC.
To: CANADA TRUST COMPANY, THE
Reel/Frame 014242/0790 →
Security Interest Feb 12, 2004
From: SYNX PHARMA INC.
To: NANOGEN, INC.
Reel/Frame 014337/0010 →
Change of Name Jul 3, 2006
From: SYN X PHARMA INC.
To: NANOGEN POINT OF CARE INC.
Reel/Frame 017881/0953 →
Assignment of Assignor's Interest Aug 29, 2006
From: NANOGEN POINT OF CARE INC.
To: NANOGEN INC.
Reel/Frame 018191/0289 →
Assignment of Intellectual Property Security Agreement Apr 15, 2008
From: THE CANADA TRUST COMPANY
To: NANOGEN, INC.
Reel/Frame 020807/0247 →
Release of Security Interest Apr 17, 2008
From: NANOGEN POINT OF CARE, INC.
To: NANOGEN, INC.
Reel/Frame 020826/0087 →
Grant of Security Interest Jul 25, 2008
From: NANOGEN, INC.
To: PORTSIDE GROWTH & OPPORTUNITY FUND, AS COLLATERAL AGENT
Reel/Frame 021291/0605 →